MFC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Manulife Financial Corp (MFC) is not a strong buy at the moment for a beginner investor with a long-term strategy. Despite positive technical indicators and analyst ratings, the company's recent financial performance shows declining revenue, net income, and EPS. Additionally, there are no significant catalysts or proprietary trading signals to suggest immediate action. The stock may be worth monitoring for better entry points or further developments in its business strategy.
The stock is currently in a bullish trend, with MACD above 0 and positively contracting, RSI indicating overbought conditions at 87.856, and moving averages showing a bullish alignment (SMA_5 > SMA_20 > SMA_200). The pre-market price is $39.35, up 1.86%, with resistance levels at R1: $38.496 and R2: $39.644.
Analysts have raised price targets recently, with RBC Capital and Scotiabank maintaining Outperform ratings. The company is in talks to acquire a 72% stake in Cellnex's Swiss unit, which could impact its asset structure positively if the deal materializes.
The company's financials for Q4 2025 show declining revenue (-1.75% YoY), net income (-9.17% YoY), and EPS (-5.68% YoY). Additionally, the RSI indicates overbought conditions, suggesting limited immediate upside potential.
In Q4 2025, Manulife Financial reported a revenue drop to $10.07 billion (-1.75% YoY), net income drop to $1.396 billion (-9.17% YoY), and EPS drop to $0.83 (-5.68% YoY). Gross margin remained unchanged.
Analysts are generally positive on the stock, with RBC Capital and Scotiabank raising price targets to C$55 and C$56, respectively, and maintaining Outperform ratings. TD Securities lowered its price target slightly to C$59 but maintained a Buy rating.
